BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7035347)

  • 1. Immunochemical analysis of anti-HLA-A2, HLA-A3, and HLA-B27 xenoantisera elicited with hybrids between human and murine cells.
    Pellegrino MA; Ng AK; Russo C; Glassy M; Ferrone S
    Immunogenetics; 1981; 14(1-2):141-52. PubMed ID: 7035347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The free and the beta 2-microglobulin-associated heavy chains of HLA-A, B alloantigens share the antigenic determinant recognized by the monoclonal antibody Q1/28.
    Quaranta V; Walker LE; Ruberto G; Pellegrino MA; Ferrone S
    Immunogenetics; 1981; 13(4):285-95. PubMed ID: 6168579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serological and immunochemical analysis of the specificity of xenoantiserum 8986 elicited with hybrids between human melanoma cells and murine fibroblasts.
    Imai K; Galloway DR; Ferrone S
    Cancer Res; 1981 Mar; 41(3):1028-33. PubMed ID: 6161692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syngeneic anti-idiotypic antisera to murine monoclonal antibodies to monomorphic and polymorphic determinants of HLA class I antigens.
    Perosa F; Tsujisaki M; Ferrone S
    J Immunol; 1987 Apr; 138(7):2202-7. PubMed ID: 2435792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-HLA-B7,B27,Bw42,Bw54,Bw55,Bw56, Bw67,Bw73 monoclonal antibodies: specificity, idiotypes, and application for a double determinant immunoassay.
    Sakaguchi K; Ono R; Tsujisaki M; Richiardi P; Carbonara A; Park MS; Tonai R; Terasaki PI; Ferrone S
    Hum Immunol; 1988 Mar; 21(3):193-207. PubMed ID: 3259570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xenoantisera to allotypic specificities of HLA-A and B antigens. Serological characterization.
    Richiardi P; Pellegrino MA; Ferrone S
    Transplantation; 1979 Oct; 28(4):333-8. PubMed ID: 92080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serologic and immunochemical characterization of HLA-A9 xenoantisera.
    Allison JP; Belvedere M; Reisfeld RA; Pellegrino MA; Ferrone S
    J Immunol; 1978 Aug; 121(2):579-85. PubMed ID: 681750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fab2 fragments from HLA xenoantisera specifically block cytolysis mediated by HLA-AB alloantisera.
    Belvedere M; Richiardi P; Pellegrino MA; Ferrone S
    J Immunogenet; 1980 Jun; 7(3):215-9. PubMed ID: 6157749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The monoclonal antibody CR11-351 discriminates HLA-A2 variants identified by T cells.
    Russo C; Ng AK; Pellegrino MA; Ferrone S
    Immunogenetics; 1983; 18(1):23-35. PubMed ID: 6190744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the repertoire of anti-HLA antibodies with anti-idiotypes to a murine anti-HLA-A2,A28 monoclonal antibody.
    Russo C; Pellegrino MA; Ferrone S
    Hum Immunol; 1984 May; 10(1):57-67. PubMed ID: 6609912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fine specificity and idiotype diversity of the murine anti-HLA-A2, A28 monoclonal antibodies CR11-351 and KS1.
    Tsujisaki M; Sakaguchi K; Igarashi M; Richiardi P; Perosa F; Ferrone S
    Transplantation; 1988 Mar; 45(3):632-9. PubMed ID: 3162340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production and characterization of DR xenoantisera: use for detection of serum DR antigens.
    Wilson BS; Indiveri F; Pellegrino MA; Ferrone S
    J Immunol; 1979 May; 122(5):1967-71. PubMed ID: 376728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Syngeneic anti-idiotypic antisera to murine anti-HLA class II monoclonal antibodies.
    Perosa F; Ferrone S
    J Immunol; 1987 Aug; 139(4):1232-9. PubMed ID: 3611788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein A binding assay for the identification of HLA antigens on peripheral blood lymphocytes by monoclonal antibodies: application to HLA B27.
    Yang YH; Grumet FC; Fendly B; Engleman E; Shively JE
    Hybridoma; 1982; 1(3):243-55. PubMed ID: 6208127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine monoclonal antibodies against HLA structures.
    Trucco MM; Garotta G; Stocker JW; Ceppellini R
    Immunol Rev; 1979; 47():219-52. PubMed ID: 95014
    [No Abstract]   [Full Text] [Related]  

  • 16. Indirect rosette microassay to characterize human melanoma-associated antigens recognized by operationally specific xenoantisera.
    Imai K; Ferrone S
    Cancer Res; 1980 Jul; 40(7):2252-6. PubMed ID: 6966965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Procedure for the selection of HLA xenoantisera for immunochemical characterization of HLA antigens.
    Allison JP; Ferrone S; Pellegrino MA; Reisfeld RA
    Transplant Proc; 1977 Mar; 9(1):601-4. PubMed ID: 194373
    [No Abstract]   [Full Text] [Related]  

  • 18. Lack of association of serologically detectable human melanoma-associated antigens with beta 2 microglobulin: serologic and immunochemical evidence.
    McCabe RP; Indiveri F; Galloway DR; Ferrone S; Reisfeld RA
    J Natl Cancer Inst; 1980 Oct; 65(4):703-7. PubMed ID: 6158590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Yersinia pseudotuberculosis protein which cross-reacts with HLA-B27.
    Chen JH; Kono DH; Yong Z; Park MS; Oldstone MM; Yu DT
    J Immunol; 1987 Nov; 139(9):3003-11. PubMed ID: 2444647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation and characterization of three new monoclonal antibodies detecting the allospecificities HLA-A2,w69, HLA-A3 and HLA-B13.
    Eiermann TH; Raghavachar A; Wölpl A; Ballas M; Fischer M; Goldmann SF
    Tissue Antigens; 1987 Apr; 29(4):201-7. PubMed ID: 3497470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.